⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL950074 | 0.69 | — | — | |
| SCHEMBL11222474 | 0.67 | — | — | |
| Carbon Dioxide SCHEMBL28217571 | 0.67 | — | — | |
| Guanidine SCHEMBL25436559 | 0.65 | — | — | |
| SCHEMBL1154963 | 0.63 | — | — | |
| Guanidine SCHEMBL8222229 | 0.62 | ALDH1A1 (0.31) | — | |
| SCHEMBL8001870 | 0.62 | — | — | |
| Guanidine SCHEMBL613955 | 0.62 | — | — | |
| Guanidine SCHEMBL28162146 | 0.60 | — | — | |
| Guanidine SCHEMBL27451533 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110039822-A1 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2011-02-17 | — | — | US | claimed |
| US-20090270376-A1 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2009-10-29 | — | — | US | claimed |
| EP-1966200-A1 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | Astellas Pharma Inc. (JP) | 2008-09-10 | — | — | EP | claimed |
| WO-2007077949-A1 | HETEROCYCLIC JANUS KINASE 3 INHIBITORS | ASTELLAS PHARMA INC. (JP) | 2007-07-12 | — | — | WO | claimed |
| CN-109535164-B | JAK kinase inhibitor, preparation method thereof and application thereof in medical field | 上海华汇拓医药科技有限公司 | 2022-01-18 | — | — | CN | disclosed |